United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund raised its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 42.8% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 117,588 shares of the healthcare conglomerate's stock after purchasing an additional 35,259 shares during the period. UnitedHealth Group accounts for 2.3% of United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund's portfolio, making the stock its 12th largest holding. United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund's holdings in UnitedHealth Group were worth $59,483,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other institutional investors and hedge funds have also modified their holdings of UNH. NewSquare Capital LLC bought a new position in UnitedHealth Group in the 4th quarter worth approximately $25,000. AlphaMark Advisors LLC acquired a new position in UnitedHealth Group during the 4th quarter valued at $30,000. Promus Capital LLC acquired a new stake in UnitedHealth Group in the 4th quarter worth $32,000. RPg Family Wealth Advisory LLC bought a new stake in shares of UnitedHealth Group in the third quarter valued at about $37,000. Finally, Pillar Financial Advisors LLC bought a new position in UnitedHealth Group during the fourth quarter valued at about $40,000. 87.86% of the stock is currently owned by institutional investors and hedge funds.
Insiders Place Their Bets
In other news, Director Timothy Patrick Flynn purchased 1,000 shares of the firm's stock in a transaction dated Friday, January 17th. The stock was bought at an average price of $511.57 per share, with a total value of $511,570.00. Following the acquisition, the director now directly owns 4,500 shares of the company's stock, valued at approximately $2,302,065. This represents a 28.57 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Company insiders own 0.33% of the company's stock.
UnitedHealth Group Trading Down 0.0 %
Shares of NYSE UNH traded down $0.25 during midday trading on Friday, hitting $515.47. The stock had a trading volume of 2,378,211 shares, compared to its average volume of 4,268,981. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $630.73. The firm has a market cap of $471.51 billion, a P/E ratio of 33.26, a price-to-earnings-growth ratio of 1.37 and a beta of 0.62. The company's 50-day simple moving average is $508.81 and its 200 day simple moving average is $544.24.
UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The company had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. During the same quarter last year, the firm earned $5.83 EPS. The company's revenue for the quarter was up 6.8% on a year-over-year basis. Research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.
UnitedHealth Group Announces Dividend
The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were issued a $2.10 dividend. The ex-dividend date was Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a yield of 1.63%. UnitedHealth Group's dividend payout ratio is presently 54.19%.
Analyst Ratings Changes
UNH has been the topic of a number of research reports. Barclays lowered their price objective on UnitedHealth Group from $655.00 to $642.00 and set an "overweight" rating on the stock in a research report on Friday, January 17th. Oppenheimer raised their price objective on shares of UnitedHealth Group from $610.00 to $640.00 and gave the stock an "outperform" rating in a report on Friday, December 6th. Cantor Fitzgerald reissued an "overweight" rating and issued a $700.00 price target on shares of UnitedHealth Group in a research report on Friday, January 17th. Deutsche Bank Aktiengesellschaft upped their price objective on UnitedHealth Group from $595.00 to $625.00 and gave the company a "buy" rating in a research note on Tuesday, December 3rd. Finally, Hsbc Global Res raised UnitedHealth Group from a "hold" rating to a "strong-buy" rating in a research note on Friday, January 10th. Twenty equities research analysts have rated the stock with a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of "Buy" and an average price target of $629.32.
View Our Latest Research Report on UNH
UnitedHealth Group Profile
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
See Also

Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.